Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel selective c-Abl inhibitor prevents neurodegeneration in models of Parkinson's

Dec. 3, 2021

BCL10/MALT1 axis found to be involved in psoriasis

Dec. 3, 2021

Orion completes OB-004 lead optimization

Dec. 3, 2021

GAT-564, a novel CB1R allosteric modulator with efficacy in murine model of glaucoma

Dec. 3, 2021

J2H Biotech synthesizes new compounds for liver cancer

Dec. 3, 2021

Bristol Myers Squibb synthesizes new galectin-3 inhibitors

Dec. 3, 2021

PMV Pharmaceuticals identifies new TP53 mutant stabilizers

Dec. 3, 2021

Merck & Co. divulges coagulation factor XIa inhibitors

Dec. 3, 2021

Accutar Biotechnology patents EGFR and/or HER2 inhibitors

Dec. 3, 2021

HCN targeting rescues chronic stress-induced cognitive deficits

Dec. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...